Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?

References

• Storry JR, Clausen FB, Castilho L, et al. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: report of the Dubai, Copenhagen and Toronto Meetings. Vox Sang. 2019;114(1):95–102.
   PubMed Web of Science ®Google Scholar
• Daniels G. Human blood groups: introduction. In: Human blood groups. 3rd ed. Oxford (UK): Wiley-Blackwell; 2013. p. 1–10.
   Google Scholar
• Mitra R, Mishra N, Rath GP. Blood groups systems. Indian J Anaesth. 2014;58(5):524–528.
   PubMedGoogle Scholar
• Fujii J, Kurahashi T, Konno T, et al. Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus. World J Nephrol. 2015;4(2):213–222.
   PubMedGoogle Scholar
• Mohanty JG, Nagababu E, Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol. 2014;5:84.
   PubMed Web of Science ®Google Scholar
• Barcellini W. The clinical dilemma and management of red cell autoantibodies. Expert Rev Hematol. 2016;9(4):325–327.
   PubMed Web of Science ®Google Scholar
• Palma J, Tokarz-Deptuła B, Deptuła J, et al. Natural antibodies – facts known and unknown. Cent Eur J Immunol. 2018;43(4):466–475.
   PubMed Web of Science ®Google Scholar
• Meulenbroek EM, Wouters D, Zeerleder SS. Lyse or not to lyse: clinical significance of red blood cell autoantibodies. Blood Rev. 2015;29(6):369–376.
   PubMed Web of Science ®Google Scholar
• Garratty G. What is a clinically significant antibody? ISBT Sci Ser. 2012;7(1):54–57.
   Google Scholar
• Saini N, Sood T, Kaur R, et al. Clinically significant IgM anti-Cw: a rare report. Indian J Hematol Blood Transfus. 2017;33(2):298–299.
   PubMed Web of Science ®Google Scholar
• Das R, Dubey A, Agrawal P, et al. Spectrum of anti-M: a report of three unusual cases. Blood Transfus. 2014;12(1):99–102.
   PubMed Web of Science ®Google Scholar
• Makroo RN, Arora B, Bhatia A, et al. Clinical significance of antibody specificities to M, N and Lewis blood group system. Asian J Transfus Sci. 2014;8(2):96–99.
   PubMedGoogle Scholar
• Hellberg A, Westman JS, Olsson ML. An update on the GLOB blood group system and collection. Immunohematology. 2013;29(1):19–24.
   PubMedGoogle Scholar
• López-Díaz PE, Ruiz-Olivera MDR, Hernández-Osorio LA, et al. Irregular antibodies in no hemolytic autoimmune diseases are able to induce erythrophagocytosis. Immunol Res. 2017;65(1):410–418.
   PubMed Web of Science ®Google Scholar
• Pahuja S, Kushwaha S, Sethi N, et al. Screening of blood donors for erythrocyte alloantibodies. Hematology. 2012;17(5):302–305.
   PubMed Web of Science ®Google Scholar
• Patidar GK. Antibody screening of healthy blood donors: it’s time to make it mandatory. J Blood Disord Transf. 2015;6:1.
   Google Scholar
• Gottvall T, Filbey D. Alloimmunization in pregnancy during the years 1992–2005 in the central west region of Sweden. Acta Obstet Gynecol Scand. 2008;87(8):843–848.
   PubMed Web of Science ®Google Scholar
• Kahar M. Frequency of red cell alloantibodies in pregnant females of Navsari district: an experience that favours inclusion of screening for irregular erythrocyte antibody in routine antenatal testing profile. J Obstet Gynaecol India. 2018;68(4):300–305.
   PubMed Web of Science ®Google Scholar
• Webb J, Delaney M. Red blood cell alloimmunization in the pregnant patient. Transfus Med Rev. 2018;32(4):213–219.
   PubMed Web of Science ®Google Scholar
• Karim F, Moiz B, Kamran N. Risk of maternal alloimmunization in Southern Pakistan – a study in a cohort of 1000 pregnant women. Transfus Apher Sci. 2015;52(1):99–102.
   PubMed Web of Science ®Google Scholar
• Chatziantoniou V, Heeney N, Maggs T, et al. A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy. Transfus Med. 2017;27(4):275–285.
   PubMed Web of Science ®Google Scholar
• Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology Am Soc Hematol Educ Program. 2016;2016(1):446–451.
   PubMedGoogle Scholar
• Tormey CA, Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood. 2019;133(17):1821–1830.
   PubMed Web of Science ®Google Scholar
• Kaur D, Bains L, Kandwal M, et al. Erythrocyte alloimmunization and autoimmunization among blood donors and recipients visiting a tertiary care hospital. J Clin Diagn Res. 2017;11(3):EC12–EC15.
   PubMed Web of Science ®Google Scholar
• Evers D, Middelburg RA, de Haas M, et al. Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study. Lancet Haematol. 2016;3(6):e284–e292.
   PubMed Web of Science ®Google Scholar
• Stahl D, Lacroix-Desmazes S, Kaveri SV, et al. Polyreactivity of disease-associated anti-RBC IgG autoantibodies of patients with warm autoimmune haemolytic anaemia and natural anti-RBC IgG autoantibodies of healthy individuals. Scand J Immunol. 2000;52(2):190–199.
   PubMed Web of Science ®Google Scholar
• Mauro FR, Trastulli F, Alessandri C, et al. Clinical relevance of silent red blood cell autoantibodies. Haematologica. 2017;102(12):e473–e475.
   PubMed Web of Science ®Google Scholar
• Hendrickson JE, Tormey CA. Red blood cell antibodies in hematology/oncology patients: interpretation of immunohematologic tests and clinical significance of detected antibodies. Hematol Oncol Clin North Am. 2016;30(3):635–651.
   PubMed Web of Science ®Google Scholar
• Papay P, Hackner K, Vogelsang H, et al. High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease. Am J Med. 2012;125(7):717.e1–717.e8.
   Web of Science ®Google Scholar
• Ryder AB, Hendrickson JE, Tormey CA. Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization. Br J Haematol. 2016;174(3):483–485.
   PubMed Web of Science ®Google Scholar
• Ramsey G, Smietana SJ. Multiple or uncommon red cell alloantibodies in women: association with autoimmune disease. Transfusion. 1995;35(7):582–586.
   PubMed Web of Science ®Google Scholar
• Tormey CA, Fisk J, Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion. 2008;48(10):2069–2076.
   PubMed Web of Science ®Google Scholar
• Singer ST, Wu V, Mignacca R, et al. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood. 2000;96(10):3369–3373.
   PubMed Web of Science ®Google Scholar
• Nickel RS, Hendrickson JE, Fasano RM, et al. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Transfusion. 2016;56(1):107–114.
   PubMed Web of Science ®Google Scholar
• Telen MJ, Afenyi-Annan A, Garrett ME, et al. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion. 2015;55(6pt2):1378–1387.
   PubMedGoogle Scholar
• Caamaño J, Musante E, Contreras M, et al. Frequency and specificity of red blood cell alloimmunization in Chilean transfused patients. Transfus Med Hemother. 2015;42(1):4–7.
   PubMed Web of Science ®Google Scholar
• Noizat-Pirenne F, Tournamille C, Bierling P, et al. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion. 2006;46(8):1328–1333.
   PubMed Web of Science ®Google Scholar
• Schonewille H, Doxiadis II, Levering WH, et al. HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies. Transfusion. 2014;54(8):1971–1980.
   PubMed Web of Science ®Google Scholar
• Hudson KE, Lin E, Hendrickson JE, et al. Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood. 2010;115(19):3989–3996.
   PubMed Web of Science ®Google Scholar
• Baine I, Bahar B, Hendrickson JE, et al. Microbial pathogen primary sequence inversely correlates with blood group antigen immunogenicity. Transfusion. 2019;59(5):1651–1656.
   PubMed Web of Science ®Google Scholar
• Fasano RM, Booth GS, Miles M, et al. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. Br J Haematol. 2015;168(2):291–300.
   PubMed Web of Science ®Google Scholar
• Zalpuri S, Evers D, Zwaginga JJ, et al. Immunosuppressants and alloimmunization against red blood cell transfusions. Transfusion. 2014;54(8):1981–1987.
   PubMed Web of Science ®Google Scholar
• Hendrickson JE, Chadwick TE, Roback JD, et al. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood. 2007;110(7):2736–2743.
   PubMed Web of Science ®Google Scholar
• Huo F, Li D, Zhao B, et al. Deficiency of autoimmune regulator impairs the immune tolerance effect of bone marrow-derived dendritic cells in mice. Autoimmunity. 2018;51(1):10–17.
   PubMed Web of Science ®Google Scholar
• Zimring JC, Hudson KE. Cellular immune responses in red blood cell alloimmunization. Hematology Am Soc Hematol Educ Program. 2016;2016(1):452–456.
   PubMedGoogle Scholar
• Torres-Aguilar H, Blank M, Kivity S, et al. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4+ T cell response to β2GPI. Ann Rheum Dis. 2012;71(1):120–128.
   PubMed Web of Science ®Google Scholar
• WHO. Blood donor selection: guidelines on assessing donor suitability for blood donation. Geneva: World Health Organization; 2012.
   Google Scholar
• Gupta N, Riaz Mehdi S, Zaidi N, et al. Alloimmunization in patients and donors visiting blood bank of a tertiary care hospital: alloimmunization in patients and donors visiting blood bank of a tertiary care hospital In North India. Natl J Integr Res Med. 2018;9(4):49–54.
   Google Scholar
• Karafin MS, Tan S, Tormey CA, et al. Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Transfusion. 2019;59(1):217–225.
   PubMed Web of Science ®Google Scholar
• Hauser RG, Esserman D, Karafin MS, et al. The evanescence and persistence of RBC alloantibodies in blood donors. Transfusion. 2020;60(4):831–839.
   PubMed Web of Science ®Google Scholar
• American Association of Blood Banks. Standards for blood banks and transfusion services. United kingdom: JPAC. 31st ed.; 2018.
   Google Scholar
• He Z, Chen Q, Chen S, et al. Is it necessary for screening irregular antibodies of blood donors? APJBG. 2018;2(1):53–58.
   Google Scholar
• Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC). Guidelines for the blood transfusion services. Available from: https://www.transfusionguidelines.org/red-book/chapter-12-donation-testing-red-cell-immunohaematology/12-10-mandatory-testing-of-blood-donations
   Google Scholar
• Sandler SG. The importance of antibody detection and identification in the chronically transfused patient. Clin Adv Hematol Oncol. 2010;8(9):611–617.
   PubMedGoogle Scholar
• New HV, Berryman J, Bolton-Maggs PH, et al. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol. 2016;175(5):784–828.
   PubMed Web of Science ®Google Scholar
• Koelewijn JM, Vrijkotte TG, van der Schoot CE, et al. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008;48(5):941–952.
   PubMed Web of Science ®Google Scholar
• Promwong C, Siammai S, Hassarin S, et al. Frequencies and specificities of red cell alloantibodies in the Southern Thai population. Asian J Transfus Sci. 2013;7(1):16–20.
   PubMedGoogle Scholar
• Zhu JY, Lan JC, Luo HQ. Screening analysis of irregular antibodies from random donor population in Shaoguan Area. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007;15(3):630–631.
   PubMedGoogle Scholar
• Bareford D, Longster G, Gilks L, et al. Follow-up of normal individuals with a positive antiglobulin test. Scand J Haematol. 1985;35(3):348–353.
   PubMedGoogle Scholar
• Bellia M, Georgopoulos J, Tsevrenis V, et al. The investigation of the significance of a positive direct antiglobulin test in blood donors. Immunohematology. 2002;18(3):78–81.
   PubMedGoogle Scholar
• Gorst DW, Rawlinson VI, Merry AH, et al. Positive direct antiglobulin test in normal individuals. Vox Sang. 1980;38(2):99–105.
   PubMed Web of Science ®Google Scholar
• Weiner W. "Coombs positive" "normal" people. Bibl Haematol. 1965;23:35–39.
   PubMedGoogle Scholar
• Fattizzo B, Zaninoni A, Nesa F, et al. Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias. Am J Hematol. 2015;90(8):E149–E151.
   PubMed Web of Science ®Google Scholar
• Torres-Aguilar H, Blank M, Jara LJ, et al. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev. 2010;10(1):8–17.
   PubMed Web of Science ®Google Scholar
• Pourazar A. Red cell antigens: structure and function. Asian J Transfus Sci. 2007;1(1):24–32.
   PubMedGoogle Scholar
• Tormey CA, Stack G. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood. 2009;114(19):4279–4282.
   PubMed Web of Science ®Google Scholar
• Rourk A, Squires JE. Implications of the Kidd blood group system in renal transplantation. Immunohematology. 2012;28(3):90–94.
   PubMedGoogle Scholar
• Dinardo CL, Fernandes FL, Sampaio LR, et al. Transfusion of older red blood cell units, cytokine burst and alloimmunization: a case-control study. Rev Bras Hematol Hemoter. 2015;37(5):320–323.
   PubMedGoogle Scholar
• Veale MF, Healey G, Sparrow RL. Longer storage of red blood cells is associated with increased in vitro erythrophagocytosis. Vox Sang. 2014;106(3):219–226.
   PubMed Web of Science ®Google Scholar
• Smith NH, Hod EA, Spitalnik SL, et al. Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs [published correction appears in Blood. 2014 Mar 27;123(13):1182]. Blood. 2012;119(6):1566–1569.
   PubMed Web of Science ®Google Scholar
• Fatone MC, Pavone F, Lauletta G, et al. Features of peripheral CD8 + CD57+ lymphocytes in patients with autoimmune hemolytic anemia. Autoimmunity. 2018;51(4):166–174.
   PubMed Web of Science ®Google Scholar
• Tang H, Bai Y, Shen W, et al. Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancer. Autoimmunity. 2018;51(4):191–198.
   PubMed Web of Science ®Google Scholar
• Heneghan MA, McCarthy CF, Janulaityte D, et al. Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity. Infect Immun. 2001;69(8):4774–4781.
   PubMed Web of Science ®Google Scholar
• Stephen J, Cairns LS, Pickford WJ, et al. Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen. Blood. 2012;119(23):5563–5574.
   PubMed Web of Science ®Google Scholar
• Basseri RJ, Schmidt MT, Basseri B. Autoimmune hemolytic anemia in treatment-naive chronic hepatitis C infection: a case report and review of literature. Clin J Gastroenterol. 2010;3(5):237–242.
   PubMedGoogle Scholar
• Hadley AG. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn. Transpl Immunol. 2002;10(2–3):191–198.
   PubMed Web of Science ®Google Scholar
• Muhammad Yusoff F, Wong KK, Mohd Redzwan N. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus. Autoimmunity. 2020;53(1):8–20.
   PubMed Web of Science ®Google Scholar